Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study

Overview of attention for article published in Journal of Clinical Oncology, November 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog
twitter: 51 X users
facebook: 1 Facebook page

video: 1 YouTube creator
guideline: 2 clinical guideline sources
bluesky: 9 Bluesky users

Readers on

mendeley: 37 Mendeley

So far, Altmetric has seen 9 Bluesky posts from 9 Bluesky users, with an upper bound of 8,346 followers.

RP @medicine.stitches.today: Patients with residual isolated tumor cells after chemotherapy show low nodal burden, making routine axillary lymph node dissection unnecessary. by Montagna G, Laws A (...) Weber WP et 47 al. in J Clin Oncol #MedSky 📖 read …

Patients with residual isolated tumor cells after chemotherapy show low nodal burden, making routine axillary lymph node dissection unnecessary. by Montagna G, Laws A (...) Weber WP et 47 al. in J Clin Oncol #MedSky 📖 read the article: https://ascopubs…

RP @maryamlustberg.bsky.social: Doing less is sometimes more #supponc #survonc #FirstDoNoHarm #bcsm ascopubs.org/doi/10.1200/...

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity, including 5 additional Bluesky posts.